Shandong Lukang Pharmaceutical Co.,Ltd. provided earnings guidance for the year 2018. According to preliminary statistics of its financial department, the Company predicts an increase of between RMB 46 million and RMB 57 million in its net profit owned by shareholders of the company in 2018 compared with the same period of the year before, with a year-on-year increase of between 40% and 50%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 41 million and RMB 49 million, with a year-on-year increase of between 55% and 65%.